Background Pancreatoduodenectomy (PD) carries a high morbidity. Over time, pancreatic surgeons have altered their perioperative management in efforts to reduce morbidity rates, thereby creating major technical and management variations. We aim to evaluate the practice patterns of hepato-pancreato-biliary (HPB) surgeons across multiple regions worldwide. Methods Between May and August 2015, an anonymous 25-item survey questionnaire was electronically distributed to the International Hepato-Pancreato-Biliary Association members regarding practice patterns and perioperative care of patients undergoing PD. Responses were analyzed based on three variables: geographical region, institution type and volume status. Results Among 285 participants, the majority were highvolume surgeons (80.4%) at academic institutions (56.1%) from the United States (34.7%), Europe (28.1%) and Asia (14.3%). North American surgeons are more likely to limit prophylactic antibiotic within 24 h postoperatively (P < 0.001), whereas European surgeons more often culture bile intraoperatively (P = 0.024). There are significant variations between different institution types and HPB surgeons based on case volume. Very-high volume surgeons (>50 cases/year) are more likely to routinely culture intraoperative bile (64% vs. 33.3-37.5%) and close incision with subcuticular sutures (42.5% vs. 15.3-25.9%).
Introduction
Pancreatoduodenectomy (PD) is the mainstay for treatment of pancreatic head and periampullary cancers. Despite advancements in perioperative care, PD is still associated with high morbidity. Over time, pancreatic surgeons have altered their perioperative management in efforts to reduce these morbidity rates. Some of these modifications are secondary to limited resources in certain institutions or based on personal observations that may or may not be congruent to current level 1 evidence.
The International Study Group on Pancreatic Surgery (ISGPS) has attempted to standardize the classification and management of complications after pancreatic surgery by using rigorous consensus protocols [1] [2] [3] . Yet, significant heterogeneity seems to exist between institutions across different centers worldwide [4] . A recent surveybased study demonstrated major variations in technical aspects of PD including anastomotic reconstruction, utilization of pancreatic stents as well as octreotide and biological sealants use [4] .
Several questions still remain unclear such as the utilization of therapeutic and prophylactic antibiotics; management of intraoperative drains and perioperative wound care. Herein, we aim to assess the practice patterns across different regions and institutions to identify potential regional bias that may facilitate further strategies towards standardization of perioperative management of PD.
Methods
From May to August 2015, a pilot cross-sectional 25-item survey questionnaire involving the International HepatoPancreato-Biliary Association (IHPBA) surgeons regarding practice patterns and perioperative care of patients undergoing PD. Demographic information was collected including geographic region, type of practice (academic, community-based or hybrid institutions), and number of PD per year. Geographic regions were divided into six groups: North America, South America (including Central America), Asia, Europe, and Oceania. "Other" regions included responders from Africa and Middle East (Israel and Lebanon), which were combined for statistical reasons. The annual volume was analyzed based on three groups: >25 cases/year, 10-25 cases/year and <10 cases/ year. High-volume (HV) surgeons were defined as those performing greater than 10 PD per year [5] . Surgeons with greater than 50 cases per year were classified as very-high volume. Institutional Review Board (IRB) approval for this study (IRB number 729831-1) was obtained, waiving the need for informed consent. This study was approved by IHPBA Research Committee.
The survey was electronically distributed using SurveyMonkey via e-mail in partnership with IHPBA ( Fig. 1) . A reminder email was sent one time for the nonresponders. Participation in the survey was anonymous and voluntary. Only responses from surgeons who completed the entire survey were included in the analysis. Questions regarding the practice patterns focused on local and systemic measures related to surgical site infection (SSI) management and prophylaxis, and monitoring of postoperative pancreatic fistula (POPF) based on drain management and laboratory work-up. Specific operative techniques related to type of anastomosis, use administration of biological sealants and prophylactic somatostatin analogues were not included in this survey.
Statistical analysis
Responses were analyzed based on demographic characteristics, including geographical region, type of practice (academic versus community institutions), and case volume. Categorical variables were analyzed with v 2 analysis or Fisher's exact test as appropriate. P-values less than 0.05 were considered statistically significant. Statistical analysis was performed with Prism© 6.0 software (GraphPad Inc., San Diego, CA, USA).
Results

Demographics and practice patterns
The survey was completed by 285 of 1,366 IHPBA members representing six continents, with a response rate of 20.9%. This total number excluded the members that had opted out from IHPBA mailing. A total of 666 members accessed the questionnaire; however, only completed surveys were included in the analysis. The majority of participants were from the United States (34.7%), Europe (28.1%) and Asia (14.3%). Most responders were from academic institutions (56.1%), and 12.6% were from community centers. Eighty-nine surgeons (31.3%) performed at academic-affiliated community hospitals. Most responders were considered HV surgeons (80%) ( Table 1) . Table 2 summarizes practice patterns related to the management and prophylaxis of infection after PD. Majority of surgeons extend perioperative antibiotic beyond 24 h postoperatively (52%). If clinically indicated, most responders (81.2%) do not extend antibiotics beyond 7 days and do not use bile cultures to determine antibiotic therapy (64.9%) ( Table 2 ). Most members do not routinely culture bile (59.5%) or intra-abdominal drain fluid (75.3%). Two self-suction drains are the preferred type of drain used (41%). Drain amylase is routinely measured in 83% of cases, usually on postoperative day 3 (46%) ( Table 3 ). The majority of responders use normal saline for wound irrigation (72.2%), staples for skin closure (57.8%), and do not use wound protectors (69.7%).
Geographical regions
There was considerable variability across different regions regarding practice patterns (Table 4) . Surgeons from Europe (53.1%) and South America (45.5%) are more likely to culture intraoperative bile than North American (36.4%) and Asian (33.3%) surgeons (P = 0.024). North American surgeons are less likely to routinely check postoperative drain amylase (80.5% vs. 91.3%, P = 0.036) or irrigate the wound with povidone-iodine solution (7.7% vs. 29.1%, P < 0.001) as compared to European members. Surgeons from North America (43.5%), Asia (48.8%) and South America (60.1%) are more likely to use two self-suction drains, whereas European surgeons (45.3%) preferentially use two drains to gravity (P < 0.001). Surgeons from North America (70.1%) and Oceania (60%) limit the prophylactic antibiotic use within 24 h of surgery as compared to European (48.8%), Asian (16.7%) and South American (36.4%) members (P < 0.001) ( Table 4) . Type of practice Surgeons from academic institutions routinely culture bile intraoperatively more often than in community institutions (46.3% vs. 22.2%, P = 0.016; Table 5 ). Members from community hospitals tend to continue prophylactic antibiotics beyond 24 h (44.4% vs. 31%, P = 0.038; Table 5 ) and are more likely to use antibiotic-based on povidonebased wound irrigation (11.8% vs. 2.7%, 20.6% vs. 6.8%, respectively, P = 0.003) as compared to those from academic institutions. Routine postoperative culture and measurement of amylase through drains, types of drains (self-suction or gravity), length of postoperative antibiotic regimen, type of skin closure and wound care were statistically similar (Table 5 ).
Case volume A higher proportion of LV surgeons were observed in Europe (21%), Asia (33%) and South America (27.3%) compared to North America (12%, P = 0.003; Table 4 ). LV surgeons are more likely to continue perioperative antibiotics beyond 24 h postoperatively (50% vs. 31.3%, P = 0.009) and use two drains (70.9% vs. 61.3%, P = 0.046), but they are less likely to routinely measure postoperative drain amylase (73.6% vs. 85.7%, P = 0.034) ( Table 6 ). No statistically significant difference was observed regarding management of infection, bile culture, or wound care ( Table 6 ). The practice patterns of very-high volume surgeons are listed in Table 7 .
Also, there seems to be a significant variability among the HV experts, especially regarding the choice of postoperative drainage. These surgeons are more likely to close the incision with subcuticular sutures (42.5% vs. 15.3-25.9%, ERCP endoscopic retrograde cholangiopancreatography, PTC percutaneous transhepatic cholangiogram, SCIP Surgical Care Improvement Project P = 0.034) and to use wound protector (44% vs. 21.1-29.9%, P = 0.032) than surgeons from the first 2 tertiles (<10 and 10-25 cases/year). Also, very-high volume surgeons are more likely to routinely culture intraoperative bile (64% vs. 33.3-37.5%, P = 0.015).
Discussion
Advances in perioperative management and operative technique have improved the mortality after PD; however, morbidity remains relatively high. There appears to be a significant heterogeneity in practice patterns of PD, including anastomotic/suture technique, stent use and drain use, as well as in the use of prophylactic somatostatin analogues, sealants and autologous tissue patches [4] . It is unknown whether these variations affect outcomes after PD. Our survey assessed the variations in practice patterns related to postoperative SSI and POPF including antibiotic use (therapeutic and prophylactic), fluid cultures, management of intraoperative drains and perioperative wound care. Surgical site infections following PD vary from 7 to 32% [6] , and contribute to increased length of hospital stay and re-admissions [7] . The presence of a postoperative SSI increases hospital costs by 32.4% after PD [8] . The extra cost incurred is estimated at $15,336 per complication, with wound infection considered as the most common infectious complication [8, 9] . More importantly, postoperative wound infection delays adjuvant chemotherapy in patients with pancreatic cancer and doubles the risk of chemotherapy omission [10] . Potential causative factors include malnutrition, preoperative biliary drainage, and surgery-related variables such as main pancreatic duct diameter, POPF, and postoperative hemorrhage [11, 12] . The Surgical Care Improvement Project (SCIP) was created by the Centers of Medicare and Medicaid Services to decrease preventable SSIs [13] . The three SCIP measures regarding antibiotics and SSI prevention include: (1) administration of antibiotics within 1 h of incision time; (2) selection of appropriate antibiotic therapy; and (3) discontinuation of antibiotic within 24 h after surgery [13, 14] . However, the duration of prophylactic antibiotic in major HPB surgery remains controversial. Recent evidence suggests that longer (72 h) broad-spectrum antibiotic coverage results in significantly less SSIs after PD compared to routine use (24 h) [15] [16] [17] . Herein, we found that less than half of surgeons are compliant with current SCIP perioperative antibiotic recommendations. The compliance with prophylactic antibiotic usage is more pronounced in North America (70%) as compared to Asia (16%), South America (36%), and Europe (49%). Also, low-volume (37%) and/or community-based surgeons (25%) are less compliant than academic surgeons (53%) and/or HV surgeons (55%). The choice of optimal antibiotic also remains controversial. In this survey, most surgeons (57%) prefer the standard agents (cephalosporin with or without metronidazole). However, piperacillin-tazobactam was shown to be superior in reducing SSI after PD as it covers Enteroccoccus and Enterobacter sp., which are not covered by SCIPapproved perioperative antibiotics [6] . In this cohort, only 9% of experts use piperacillin-tazobactam as prophylactic antibiotic.
Preoperative biliary decompression with stenting seems to be the strongest predictor of postoperative wound infection. The effect of bacteriobilia found on intraoperative bile culture is associated not only with wound infection but also with sepsis [18, 19] . The initial intraoperative bile culture determines the microbiology of postoperative wound infection [20] . Some experts recommend that intraoperative bile cultures should be routinely obtained during PD to predict microorganisms isolated in wound cultures and allow for tailored antibiotic therapy in the setting of pending or unavailable wound culture data, especially if there has been preoperative biliary manipulation [20] . However, intraoperative sampling of bile during PD is not common practice. In this survey, we found that the majority of surgeons (60%) do not culture bile intraoperatively or select antibiotic based on bile culture results. European surgeons (53%) seem to routinely culture bile more often than surgeons from other regions (14-45%). Also, academic surgeons (47%) and very-high volume surgeons (64%) routinely culture more than surgeons from community institutions (22%) or low-and medium-volume surgeons (33-37%). The efficacy of routine bile culture in selected high-risk patients such as those with preoperative stenting needs further investigation.
Other perioperative measures associated with SSIs may also play a role. Wound protectors were introduced to provide mechanical adhesive barrier to the wound and, therefore minimize endogenous cross-contamination. A recent meta-analysis including 1,008 patients demonstrated that wound protector reduced the rates of SSIs after gastrointestinal and biliary surgery [21] . A randomized controlled trial evaluating the efficacy of wound protector in PD is currently underway and results are forthcoming [22] . The lack of level I recommendations may explain the low number of surgeons currently using wound protector (30%). However, we observed that European surgeons (44%) significantly utilize wound protector more often than other regions (13-35%). Also, very-high volume surgeons seem to use wound protector more often than other groups (44% vs. 21-37%) Another significant variation is the method of wound irrigation. Although the majority of experts (72%) uses normal saline as the preferred type of wound irrigation, a higher proportion of European surgeons (23%) use povidone-based solution as compared to other regions (6-7%). The impact of this practice pattern needs to be further scrutinized, as there is no comparison between these approaches in the literature. Postoperative pancreatic fistula is the determinant morbidity factor after PD [23] . The median total hospital costs for a patient with an anastomotic leakage are three times more than the costs of a patient without complications [8] . Routine use of externalized intraperitoneal drains has traditionally been considered mandatory in major pancreatic resections. Drains act as a warning of anastomotic leakage and hemorrhage, and are used to evacuate pooling of potential colonized fluid after surgery. However, this practice pattern has been recently questioned as a potential harm may be induced by mechanical pressure, erosion or suction adjacent to pancreatico-enteric anastomosis. Multiple retrospective and prospective data have published the safety of PD without routine intraperitoneal drains [24] [25] [26] [27] [28] . However, a recent multi-institutional randomized clinical trial showed that the elimination of routine drainage increases the severity and frequency of complications and is associated with 4-fold mortality increase [29] . Patients with negligible or low risk for the development of POPF (according to the Fistula Risk Score [30] ) do not require drains, whereas those with moderate or high risk for fistula benefit from drain placement [31] . In this survey, only 5% of surgeons do not use routine intraperitoneal drains. Although the majority of experts (63%) use two drains, the preferred drain type is controversial. Surgeons from most regions use two self-suction drains (43.9-60.6%), whereas European surgeons use primarily two drains to gravity (41%).
Another point of ongoing debate involves the ideal timing of drain removal. Early drain removal may be associated with reduced abdominal complications [32] . Furthermore, Bassi et al. [33] demonstrated the efficacy of early drain removal [postoperative day (POD) 3] in patients with low-risk for pancreatic fistula formation as defined as drain amylase ≤5,000U/L on POD 1 [34] . A prolonged period of drain in these low-risk patients is associated with a higher rate of postoperative complications with increased hospital stay and costs [33] . Despite these findings, only 7% of surgeons check drain amylase on POD 1, of whom 55% are from North America. The vast majority use POD 3 as the preferred timing. We did not evaluate the timing of drain removal in this study, however, McMillan et al. [4] . demonstrated that less than half of the surgeons remove drains based on early (POD ≤3) drain amylase values. This is more evident in North America, where less than a third of surgeons follow this practice as opposed to higher proportion among European (50%) and Asian (54%) surgeons [4] . We acknowledge that our study has several limitations that are intrinsic to the nature of surveys. There was relatively low number of responses initially, therefore the survey needed to be re-submitted. It is possible that the members who responded to the survey may differ in their demographic characteristics and practice patterns compared with those who did not. Also inherent bias may exist with a survey including only HPB experts, which may not be extrapolated to surgeons from other specialties. Furthermore, some important variables were not assessed, such as fellowship training, years in practice, type of anastomotic reconstruction, and timing for drain removal.
In conclusion, this survey found significant variations in perioperative management and practice patterns related to PD across different geographical regions, institution types and surgeons stratified by case volume. Some of these variations are due to controversial approaches, which are currently under debate. Further studies are warranted to elucidate the impact of these disparities on outcomes of patients undergoing PD. These findings may assist to create strategies towards standardization of care of this complex operation.
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